Results 311 to 320 of about 89,117 (340)

Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.

European Journal of Cancer, 2015
M. Del Fabbro, G. Gallesio, M. Mozzati
semanticscholar   +1 more source

Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment

Lancet Oncology, The, 2006
Michael A. Siegel
exaly  

Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide

Journal of Bone and Mineral Metabolism, 2015
N. Miyakoshi, T. Aizawa, S. Sasaki, S. Ando, Shigeto Maekawa, H. Aonuma, H. Tsuchie, H. Sasaki, Y. Kasukawa, Y. Shimada   +9 more
semanticscholar   +1 more source

Risk of Atypical Femoral Fracture during and after Bisphosphonate Use

New England Journal of Medicine, 2014
Jörg Schilcher, Karl Michaëlsson
exaly  

Bisphosphonate

Monatsschrift Kinderheilkunde, 2000
F. Rauch, E. Sch�nau, F. H. Glorieux
openaire   +1 more source

Bisphosphonate

Der Onkologe, 2003
I. A. Adamietz, I. J. Diel
openaire   +1 more source

Bisphosphonate therapy for osteogenesis imperfecta.

Cochrane Database of Systematic Reviews, 2014
K. Dwan, C. Phillipi, R. Steiner, D. Basel   +3 more
semanticscholar   +1 more source

Oral bisphosphonate use may protect women from breast cancer

Nature Reviews Clinical Oncology, 2010
Rebecca Kirk
exaly  

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

Journal of Pharmacology and Experimental Therapeutics, 2002
J. Wood, K. Bonjean, S. Ruetz, A. Bellahcène, L. Devy, J. Foidart, V. Castronovo, Jonathan R. Green   +7 more
semanticscholar   +1 more source

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

American Journal of Medicine, 2013
M. McClung, S. T. Harris, P. Miller, D. Bauer, K. Davison, L. Dian, D. Hanley, D. Kendler, C. K. Yuen, E. Lewiecki   +9 more
semanticscholar   +1 more source